Department of Surgery
School of Medicine Queen's University
 

Dr Ken Reid

Dr Ken Reid, Thoracic Surgeon, Queen's University, Kingston General HospitalUniversity Position:
Associate Professor and Thoracic Division Chair

Current Appointments:
Attending Staff, Kingston General Hospital
Attending Staff, Hotel Dieu Hospital

Areas of Clinical Interest:
Thoracic Surgery

Areas of Research Interest:






Contact Information:

Richardson House
Kingston General Hospital
102 Stuart Street
Kingston, ON
K7L 2V6
Tel: (613) 548-2383
Fax: (613) 549-2902

Click here to email Dr Reid


Fellowship:
1989‑90    Clinical Fellow, Cardiopulmonary Transplantation and Critical Care Medicine (18 months), University of Western Ontario, London, Ontario, Canada

Residency:
1983-87   General Surgery Residency, University of Ottawa
1986-87   Chief Resident, General Surgery, University of Ottawa
1987-89   Chief Resident, Thoracic Surgery, University of Ottawa

Medical School Graduation:
1978-82    Medical School, University of Ottawa

Certification:
1989        Licensure:CPSO Independent practice.
1989        Certificate of Special Competency in Thoracic Surgery ‑ Royal College of Surgeons of Canada, November 22, 1989

Professional Memberships:
• Ontario Association of Thoracic Surgeons (2007-)
• Canadian Association of Thoracic Surgeons (1998)
• American College of Chest Physicians (1987)
• Canadian Critical Care Society (1990-95)
• Interntional Association for the Staging of Lung Cance (IASLC) (2008-)
• Canadian Society of Cardiovascular and Thoracic Surgeons (1990-98)
• College of Physicians and Surgeons of Ontario (1982)
• International Society for Heart Transplantation (1990-92)
• Ottawa Lung Cancer Study Group (1991-95)
• Royal College of Physicians and Surgeons of Canada (1987-)
• Society of Critical Care Medicine (1991 - 1995)
• Trauma Association of Canada (1993-2004)

Committees:
• 2004-6             Canadian Association Thoracic Surgery Executive Member
• 2004-6             Member, Canadian Associtaion of Thoracic Surgery research Committee
• 2000-Dec 05    Member, Ontario Provincial Trauma Network
• Jul 98-Jul 01     Chair, Royal College Thoracic Surgery Examination Board
• Jul 96-01          Member, Royal College Thoracic Surgery Examination Board
• Jul 97-Dec 05   Member, Trauma Registry Advisory Committee (MOHLTC)
• Jun 99 - 00       President, Combined Kingston General and Hotel Dieu Medical Staff
• Jun 98 - 99       Vice-President, Combined Kingston General and Hotel Dieu Medical Staff     
• Jun 97 - 98       Secretary, Combined Kingston General and Hotel Dieu Medical Staff
• 1993 - 95         Member, University of Ottawa Expert Panel on Critical Care
• 1993-95           Member, OGH Research Ethics Board
• 1992-93           Member, OGH-MAC Research Committee
• 1992                Co-chairman, Critical Care University of Ottawa Strategic Planning
• 1991-95           Member, OGH Intensive Care Unit Committee
• 1991-95           Member, OGH ICU Morbidity and Mortality Review Committee

Awards:
• 1987          Special award for best research paper presentation at Surgical Residents' Review Day, University of Ottawa   
• 1991          PAIRO Clinical Teacher’s Travel Award, University of Ottawa.
• 1991-92     Ottawa General Hospital Clinical Teacher of the Year award
• 1993-94     Ottawa General Hospital Clinical Teacher of the Year award.

Presentations:
American College of Chest Physicians:
1.     Gastric Phytobezoar as a Result of Heart‑Lung Transplantation.
    ACCP Annual Meeting, Toronto, Ontario. October, 1990.

Canadian Association of Clinical Surgeons:
1.    Major Airway Injuries: Diagnosis and Management. Annual Meeting, Ottawa, Ontario. May 2, 1992.

Canadian Thoracic Society :
1.     The Assessment of Pulmonary Risk Factors in Patients Undergoing Pulmonary Resection. Royal College of Physicians and Surgeons Annual Meeting, Winnipeg, Manitoba, September, 1987.

Canadian Society of Cardiovascular and Thoracic Surgeons:
1.    Tracheo‑Bronchial Trauma : A Ten Year Experience at a University Center.
    Royal College of Physicians and Surgeons Annual Meeting, Ottawa, Ontario,  September, 1988.

International Society for Heart Transplantation :
1.    Reduced Incidence of Severe Infection After Cardiac Transplantation Using Low     Intensity Immunosuppression. Ft. Lauderdale, Fla.  April, 1990.

Canadian Transplantation Society:
1.     Low‑Intensity Immunosuppression : Diminished Incidence of Severe Infection After Heart Transplantation.  Royal College of Physicians and Surgeons of Canada, Toronto, Ontario, September, 1990.

University of Ottawa:
1.    Which Intravenous Fluid? University of Ottawa Annual Update in Critical Care     Medicine. May 2, 1992

2.    Pulmonary Contusion: How to Deal with a Battered lung.
    Post Graduate Course for General Surgeons. Nov 29,1991.

3.    Intubation and Extubation: Signs of Impending Disaster
    Post Graduate Course for General Surgeons. November,1992.

4.    Esophageal Perforation: Now What?
    Post Graduate Course for General Surgeons. Nov 29,1992.

SENORA:
1.Thoracic Trauma – An Overview, January 2004.


Abstracts/Posters:

1.    Reid KR, Shamji, F.M., and Sachs, H.J. The Assessment of Pulmonary Risk Factors in Patients Undergoing Pulmonary Resection. Clinical and Investigative Medicine. Vol 10:4 Pg B119, 1987.

2.    Reid KR, Shamji, F.M., Belanger, R., Crepeau, A. The Role of Routine Multiorgan Scanning in the Initial Staging of Carcinoma of the Lung. Chest 1987;92:2

3.    Reid KR, Shamji, F.M. Tracheo‑Bronchial Trauma : A Ten Year Experience at a     University Center. The Canadian Journal of Surgery,1988;31:273‑274.

4.    Reid KR. Low‑Intensity Immunosuppression : Diminished Incidence of Severe     Infection After Heart Transplantation. Clinical and Investigative     Medicine.1990;13:B84(supplement).

5.    Menkis AH, Reid KR, Novick RJ, Pflugfelder PW,  Kostuk WJ, McKenzie FN. Successful Management of Life‑Threatening Mediastinitis in Heart and Heart‑Lung Transplant Recipients. Can J Surgery 1990:33;324‑325.

6.    Novick RJ, Menkis AH, McKenzie FN, Reid KR, Pflugfelder PW, Kostuk WJ, and     Ahmad D. Prednisone is not Deleterious to Airway Healing Following Lung and     Heart‑Lung Transplantation. Chest 1990:98;7S.

7.    Reid K, Shamji FM, Sachs HJ,, Todd TRJ. Traumatic Tracheal Injuries. Chest     1993:104;2;37S.

8.    Lochrin C, Goss G, Cross P, Stewart D, Tomiak E, Agboola O, Aref I, Reid K, Girard A, Logan D, Crepeau A, Dahrouge S, Evans WK. Concurrent Daily Chemotherapy With Hyperfractionated Thoracic Irradiation in Stage IIIA and B NSCLC. Eur J of Cancer 1995:31A, S229

9.    Smith GBJ, Ali SL, Conlan AA, Reid K, Petsikas D, and Massey TE.  Lack of Correlation Between CYP1A1 Genotype and Associated Enzymatic Activities in Non-Tumourous Peripheral Human Lung. Toxicologist 36:23 1997.

10.Lee RP, Reid K, Petsikas D, and Forkert PG. Metabolism of Vinyl Carbamate (VC) by CYP2E1 in Human Pulmonary Microsomes: Formation of DNA Etheno Adducts. Society of Toxicology.

11.Smith GBJ, Casonguay A, Donnelly PJ, Reid K, Petsikas D, and Massey TE.  Human Lung Cell-Specific Biotransformation of the Tobacco carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-butanone(NNK). Proc. Soc. Toxicol. Can. 1997.

12.Smith GBJ, Castonguay A, Donnelly PJ, Reid K, Petsikas D, Massey TE. Human Lung Cell-Specific Biotransformation of the Tobacco carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-butanone(NNK). Toxicologist 42(1-S):285;1998.

13.Stewart RK, Smith GBJ, Donnelly PJ, Reid KR, Petsikas D, Conlan AA, Massey TE. Differential Cellular distribution of glutathione S-transferase-catalyzed conjugation of bioactivated aflatoxin B1 in human lung. ISSX Proceedings, 13:179, 1998.

14.Smith GBJ, Ali SL, Conlan AA, Reid K, Petsikas D, Bell DA, Massey TE. The CYP1A1 genetic polymorphisms and related metabolic activities in human lung. Toxicologist 36:23, 1997.

15.Smith GBJ, Castonguay A, Donnelly PJ, Reid K, Petsikas D, Massey TE. Effects of Cytochrome P450 (P450) inhibitors on biotransformation of the tobacco specific nitrosamine 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-butanone(NNK) in freshly isolated human lung cells. Toxicologist (accepted).

16.    Gilbert S, Reid K, Petsikas D. Who Should Follow Lung Cancer Patients After Surgery?  STS, Chicago Nov 1999.

17.    Smith GBJ, Reid KR, Petsikas D, Bolt MW, Massey TE. Biotransformation of the tobacco carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-butanone(NNK ) in preparations of polymorphonuclear leucocytes isolated from peripheral human lung. Proc. Amer. Soc. Cancer Res 41:571, 2000.

18.    Smith GBJ, Reid KR, Petsikas D, Bolt MW, Massey TE. Inhibition of  4-(Methylnitrosamino)-1-(3-Pyridyl)-1-butanone (NNK) bioactivation in freshly isolated human lung cells. Proc. Soc. Toxicol. Canada, 2000.

19.    Bedard LL, Smith GBJ, Reid KR, Petsikas D, Masset TE. Bioactivation of the tobacco-specific nitrosamine NNK in human lung cytosols. Toxicologist, 60:95-96, 2001.

20.    Smith GBJ, Reid KR, Petsikas D, Bolt MW, Massey TE. Effecvts of xenobiotic-metabolizing enzyme inhibitors on bioactivation of the tobacco-specific nitrosamine 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-butanone(NNK) in freshly isolated human lung cells. Proc. Amer. Soc. Cancer Res., 42: 809-810, 2001.

21.    Smith GBJ, Harper PA, Wong JMY, Lam MSM, Reid KR, Petsikas D, Massey TE. Effects of CYP1A1, AHR, and GSTM1 genetic polymorphisms and smoking status on human pulmonary CYP1A1 activities.  Proc 9th Int. Congr.
Toxicol., 2001.

22.    L.L. Bedard, G.B.J. Smith, K.R. Reid, D. Petsikas, and T.E. Massey.
Bioactivation of the tobacco-specific nitrosamine NNK in human lung cytosols.
Toxicologist, 60: 95-96, 2001.

23.    G.B.J. Smith, K.R. Reid, D. Petsikas, M.W. Bolt, and T.E. Massey.  Effects
of xenobiotic-metabolizing enzyme inhibitors on bioactivation of the
tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
(NNK) in freshly isolated human lung cells.  Proc. Amer. Soc. Cancer Res., 42:
809-810, 2001.

24.    L.L. Bedard, K.R. Reid, D. Petsikas, T.E. Massey. The Role of Lipoxygenase
in the Bioactivation of the Tobacco-Specific Nitrosamine
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Proc. Soc. Toxicol.
Canada, 2001.

25.    L.L. Bedard, G.B.J. Smith, K.R. Reid, D. Petsikas, T.E. Massey.  Human lung
cell cytosols catalyze the bioactivation of the tobacco-specific nitrosamine
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).  Toxicologist, Accepted.

26.    L.L. Bedard, G.B.J. Smith, K.R. Reid, D. Petsikas, T.E. Massey.  Human lung cell cytosols catalyze the bioactivation of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).  Toxicologist, 66: 230, 2002

27.    A.L. McGuire, D. Petsikas, K. Reid, W. Hopman. Outcomes:Wedge resection versus lobectomy for non-small cell lung cancer at the Cancer Centre of Southeastern Ontario, 1998-2009. Can J Surg 53, Supp S34, 2010.

28.    Rocca, N., McGraw, R., O’Connor, L., Reid, K. Teaching Medical Students to Break Bad News Using Simulation, Role-Play and Interprofessional Learning. Presented at Canadian Assocition of Emergency Physicians, June 2010.     Montreal, Quebec.

29.    A McGuire, K Reid, D Petsikas, W Hopman. Survival Outcomes for Never-Smokers versus Smokers with Non-Small Cell Lung Cancer at the Cancer Centre of Southeastern Ontario, 1998-2009. Can J Surgery Suppl August 2011, Page S29.

Publications:

1.    Reid KR, Menkis AH, McKenzie FN, Novick RJ, Pflugfelder PW, Kostuk WJ, Ahmad D. The Importance of Chronic Aspiration in Heart Lung Recipients. The Lancet 1990;336:206 8.

2.    Reid KR, Menkis AH, Novick RJ, Pflugfelder PW, Kostuk, WJ, Reid J, Whitby JL, Powell AM, McKenzie FN. Reduced Incidence of Severe Infection After Cardiac Transplantation Using Low Intensity Immunosuppression. J Heart and Lung Transplant 1991;10:894-900.
 
3.    Novick RJ, Menkis AH, McKenzie FN, Reid KR, and Ahmad D. Should Heart  Lung Transplant Donors and Recipients be Matched According to Cytomegalovirus Serology? J Heart and Lung Transplant 1990;9:699-706.

4.    Novick RJ, Ahmad D, Menkis AH, Reid KR, Pflugfelder PW, Kostuk WJ, and McKenzie FN. The Importance of Acquired Diffuse Bronchomalacia in Heart Lung Transplant Recipients With Obliterative Bronchiolitis. J Thorac Cardiovasc Surg 1991:101;643-648.

5.    Novick RJ, Menkis AH, McKenzie FN, Reid KR, Pflugfelder PW, Kostuk WJ, and Ahmad D. Reduction in Bleeding After Heart Lung Transplantation: The Importance of Posterior Mediastinal Hemostasis. Chest 1990;98:1383-1387.

6.    Novick RJ, Reid KR, Denning L, Duplan J, Menkis AH, and McKenzie FN. Prolonged Preservation of Canine Lung Allografts: the Role of Prostaglandins.
    Annals of Thoracic Surgery 1991;51:853-859.

7.    Novick RJ, Menkis AH, McKenzie FN, Reid KR, Pflugfelder PW, Kostuk WJ, and Ahmad D. The Safety of Low-Dose Prednisone Before and Immediately After     Heart-    Lung Transplantation. Annals of Thoracic Surgery 1991;51:642-645.

8.    Lorimer JW, Reid KR, Raymond F. Blunt Extraperitoneal Rupture of the Right Hemidiaphragm: Case Report. J Trauma 1994:36;414-416.

9.    Corsten MJ, Shamji FM, Odell PF, Frederico JA, Laframboise GG, Reid KR, Vallieres E, Matzinger FR. Descending Necrotizing Fasciitis: The Optimal Treatment.  Thorax  1997 52:8:702-708.

10.    Donnelly PJ, Stewart RK, Ali SL, Conlan AA, Reid KR, Petsikas D, Massey TE.
Biotransformation of Aflatoxin B1 in Human Lung. Carcinogenesis 1996:Vol 17:no. 11 Pp 2487-2494.

11.    Odell MJ, Reid KR. Does Percutaneous Fine Needle Aspiration of Lung Masses Aid in the Surgical Management of Suspected Carcinoma of the Lung? Can J Surgery 42:4 297-301, 1999.

12.    Tomai E, Brownell HL, Tufescu TV, Raptis S, Reid K, Campling B, Raptis L. A Functional Assay for Intercellular, Junctional Communication in Cultured Human Lung Carcinoma Cells. Lab Invest 1998 Vol 78:5:639-640.

13.    Dowsley TF,  Reid K, Petsikas D, Ulreich,JB, Fisher RL, Forkert P-G. Cytochrome P-450-dependent bioactivation of 1,1-dichloroethylene to a reactive epoxide in human lung and liver microsomes. J.Pharmacol.Exp.Ther. 289:641-648, 1999
 
14.    Smith GBJ, Castonguay A, Donnelly PJ, Reid KR, Petsikas D, Massey TE. Biotransformation fof the tobacco-specific carcinogen 4-(methylnitrosamine)-1- (3-pyridyl)-1-butanone(NNK) in freshly isolated human lung cells. Carcinogenesis Vol 20, no. 9 pp 1809-1818, 1999.

15.    Stewart RK, Smith GBJ, Donnelly PJ, Reid KR, Petsikas D, Conlan AA, Massey TE. Glutathione S-transferase-catalyzed conjugation of bioactivated aflatoxin B1 in human lung: differential cellular distribution and lack of significance of the GSTM1 genetic polymorphism.  Carcinogenesis Vol 20, no. 10 pp 1971-1977, 1999.

16.    Sebastien Gilbert MD,  Kenneth R. Reid MD, Miu Y. Lam PhD, and Dimitri Petsikas MD. Who should Follow Up Lung Cancer Patients After Operation?. Ann Thorac Surg 2000;69:1696-700.

17.    Poh-Gek Forkert, Raymond P. Lee, Ken Reid. Involvement of CYP2E1 and Carboxylesterase Enzymes in Vinyl Carbamate metabolism in Human Lung Microsomes. Drug metabolism and Disposition 29:258-263, 2001

18.    Kuzak N, O’Connor M, Pickett W, O’Brien T, Reid K. Pearson M. Evaluation of a Prison Triage System. CJEM. Vol 3 No. 3 July 2001.Pages 199-204.

19.    Gilbert S, Reid KR, Petsikas D. Reply to Correspondence. Ann  Thor Surg 71:757, 2001.

20.     Smith GBJ, Harper PA, Wong JMY, Lam MSM, Reid KR, Petsikas D, Massey TE. Human lung miscrosomal cytochrome P4501A1 activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase     M1 genetic polymorphisms. Cancer Epid. Biomark. Preven. 10: 839-853, 2001.

21.    Bedard LL, Reid KR, Petsikas D, and Massey TE. Investigation of the role of lipoxygenase in bioactivation of 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung. Chem Res Toxicol, 15:1267-1273, 2002.

22.    G.B.J. Smith, J.R. Bend, K.R. Reid, D. Petsikas, and T.E. Massey.  Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in peripheral human lung microsomes.  Drug Metab. Dispos. 31:1134-1141,2003.

23.    Pamela J. Brown, Leanne L. Bedard, Ken R. Reid, Dimitri Petsikas, Thomas E. Massey. Analysis of CYP2A13 Contributions to Metabolism of 4-(Methjylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in Human Peripheral Lung Miscrosomes. Drug Metabolism and Disposition. 35:11 2086-94, 2007.

24.    Gannon, B. R. O'Hara, C. D. Reid, K. Isotalo, P. A. Solitary fibrous tumor of the anterior mediastinum: a rare extrapleural neoplasm. Tumori. 2007 Sep-Oct;93(5):508-10.

25.      Manduch, M.Dexter, D. F., Ellis, P. M., Reid, K., Isotalo, P. A. Extraskeletal Ewing's sarcoma/primitive neuroectodermal tumor of the posterior mediastinum with Involvement of the Spinal Canal. Tumori 94:6 888-891. 2008.

26.       McGuire A, Hoopman W, Petsikas D,  Reid K. Outcomes: Wedge Resection Versus Lobectomy for Non-Small Cell Lung Cancer at the Cancer Centre of Southeastern Ontario 1998-2009. Can J Surgery  2013;56(6)E165-E170.

Submitted to Peer-Reviewed Journals

Nasirzadeh R,  Walker GR, Reid K, Dhillon G. Ectopic thyroid in the anterior mediastinum:  Case report and literature review. Submitted Annals of Thoracic Surgery July 2013.

Non-Peer-Reviewed Publications

Reid KR, Leasa DJ, and Sibbald WJ. The Postoperative Monitoring of the Thoracic Surgical Patient. Todd TRJ (ed). Critical Care in General Thoracic Surgery, Chest Surgery Clinics 1991:1;317-336.

Submitted Works:
Gene-smoking interaction for the hOGG1 Ser326Cys and XRCC3 Thr241Met DNA repair polymorphisms and lung cancer.. Erin C Pichora, Will D. King, Ken R. Reid,
Dimitri Petsikas, Thomas E. Massey. Cancer Epidemiology, Biomarkers & Prevention

Analysis of CYP2A13 Contributions to Metabolism of 4-(Methylnitrosamino)-1-(3-pyridyl)-1butanone(NNK) in Human Peripheral Lung Microsomes. Pamela J. Brown, Leanne L. Bedard, Ken R. Reid, Dimitri Petsikas, and Thomas E. Massey


Research Activities:
Local Principal Investigator:

NCIC CTG BR-19 – A Phase III Prospective, Randomized, Double-Blind, Placeb0-Controlled Trial of the Epidermal Growth Factor Receptor Antagonist ZD1839 (IRESSA) in Completely Resected Primary Stage IB, II, and IIIA Non-Small Cell Lung Cancer ONGY-202—3  (Closed to accrual 2006)

Co-investigator:
RADIANT OSI-774-302 A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Single Agent Tarceva (erlotinib) Following Complete Tumour Resection  and with or without Adjuvant Chemotherapy in Patients with Stage IB-IIIA Non-Small Cell Lung Cancer Who Have EGFR-Positive Tumours. (June, 2007 - 2009)

Co-Investigator:
Utilization of Stereotacitc Radiotherapy and Surgery in Early Stage Non-Small Cell Lung Cancer in Ontario between 2003-2012 . Queen’s University Department of Oncology
Kingston General Hospital Foundation Cancer Research Fund INTERDISCIPLINARY CANCER RESEARCH GRANT (Applied July 2013)

H.M. Fikree, P.J. Brown, G.S. Yost, K.R. Reid, D. Petsikas, and T.E. Massey.  Investigation of the biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by cytochrome (CYP) P450 2F.  In preparation.
 
G.B.J. Smith, J.E.Mulder, P. J. Brown, K.R. Reid, D. Petsikas, and T.E. Massey.  Evaluation of contributors to biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in freshly isolated human lung cells.  In preparation.

CME Activities:

Organized a CME course by the Department of Surgery: “Doc, I Just had an Operation and…(Problems encountered by the Family Physician with their Recently Discharged surgery Patients)”  Feb, 1998

An Apporach to the Solitary Pulmonary Nodule, Belleville CCO Talk, May 2006

Thoracic Trauma – An Overview,. SENORA (South Eastern Nurses Operating Room Association). January 2004.

Grants Funded:
1)    Metabolic Activation of Urethrane in Human lung Tissues.
       Drs. P-G Forkert, K. Reid, D. Petsikas
       MRC Grant  1995

2)    Study of Metabolism of Toxic and Carcinogenic Chemicals in Human Lung Tissue.              Drs. T. Massey, K. Reid, D. Petsikas
       MRC Grant Feb/96

3)    CIHR Grant for Biotransformation and Molecular Toxicity of Pulmonary Carcinogens         (2002-2007) for $115,816. Drs Thomas Massey (Pharmacology and Toxicology),               K.   Reid, D. Petsikas.

4)    CIHR Grant for Biotransformation and Molecular Toxicity of Pulmonary Carcinogens         (2008-2013) for $186,180. Drs. Thomas Massey (pharmacology and Toxicology),         K.    Reid.


Updated: Feb 26, 2015